111 related articles for article (PubMed ID: 7770702)
1. Histopathological and ultrastructural changes in the juxtaglomerular apparatus of the rat following administration of ZENECA ZD6888 (2-ethyl-5,6,7,8-tetrahydro-4-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)- methoxy]quinoline), an angiotensin II antagonist.
Jackson DG; Jones HB
Toxicol Pathol; 1995; 23(1):7-15. PubMed ID: 7770702
[TBL] [Abstract][Full Text] [Related]
2. The effects of ZENECA ZD8731, an angiotensin II antagonist, on renin expression by juxtaglomerular cells in the rat: comparison of protein and mRNA expression as detected by immunohistochemistry and in situ hybridization.
Doughty SE; Ferrier RK; Hillan KJ; Jackson DG
Toxicol Pathol; 1995; 23(3):256-61. PubMed ID: 7659950
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural juxtaglomerular cell changes in normotensive rats treated with quinapril, an inhibitor of angiotensin-converting enzyme.
Dominick MA; Bobrowski WF; Metz AL; Gough AW; MacDonald JR
Toxicol Pathol; 1990; 18(3):396-406. PubMed ID: 2267499
[TBL] [Abstract][Full Text] [Related]
4. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
6. The morphology of juxtaglomerular cell hyperplasia and hypertrophy in normotensive rats and monkeys given an angiotensin II receptor antagonist.
Owen RA; Molon-Noblot S; Hubert MF; Kindt MV; Keenan KP; Eydelloth RS
Toxicol Pathol; 1995; 23(3):606-19. PubMed ID: 7659963
[TBL] [Abstract][Full Text] [Related]
7. The morphology of juxtaglomerular cell hyperplasia and hypertrophy in normotensive rats and monkeys given an angiotensin II receptor antagonist.
Owen RA; Molon-Noblot S; Hubert MF; Kindt MV; Keenan KP; Eydelloth RS
Toxicol Pathol; 1994; 22(6):606-19. PubMed ID: 7732278
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural immunocytochemical localization of renin and angiotensin II in the juxtaglomerular cells of the ischemic kidney in experimental renal hypertension.
Cantin M; Gutkowska J; Lacasse J; Ballak M; Ledoux S; Inagami T; Beuzeron J; Genest J
Am J Pathol; 1984 May; 115(2):212-24. PubMed ID: 6372495
[TBL] [Abstract][Full Text] [Related]
9. Evidence for intracellular generation of angiotensin II in rat juxtaglomerular cells.
Mercure C; Ramla D; Garcia R; Thibault G; Deschepper CF; Reudelhuber TL
FEBS Lett; 1998 Feb; 422(3):395-9. PubMed ID: 9498824
[TBL] [Abstract][Full Text] [Related]
10. In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
Olins GM; Corpus VM; McMahon EG; Palomo MA; Schuh JR; Blehm DJ; Huang HC; Reitz DB; Manning RE; Blaine EH
J Pharmacol Exp Ther; 1992 Jun; 261(3):1037-43. PubMed ID: 1602371
[TBL] [Abstract][Full Text] [Related]
11. Development and fate of the secretory granules of juxtaglomerular epithelioid cells.
Taugner R; Metz R
Cell Tissue Res; 1986; 246(3):595-606. PubMed ID: 3539354
[TBL] [Abstract][Full Text] [Related]
12. Hyperplasia of juxtaglomerular cells and renin localization in kidney of normotensive animals given captopril. Electron microscopic and immunohistochemical studies.
Zaki FG; Keim GR; Takii Y; Inagami T
Ann Clin Lab Sci; 1982; 12(3):200-15. PubMed ID: 7046618
[TBL] [Abstract][Full Text] [Related]
13. Granular juxtaglomerular cells and prorenin synthesis in mice treated with enalapril.
Berka JL; Alcorn D; Coghlan JP; Fernley RT; Morgan TO; Ryan GB; Skinner SL; Weaver DA
J Hypertens; 1990 Mar; 8(3):229-38. PubMed ID: 2159503
[TBL] [Abstract][Full Text] [Related]
14. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural changes in the sheep renal juxtaglomerular apparatus in response to sodium depletion or loading.
Hill PA; Coghlan JP; Scoggins BA; Ryan GB
Pathology; 1983 Oct; 15(4):463-73. PubMed ID: 6371683
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin converting enzyme inhibition on glomerular number, juxtaglomerular cell activity and renin content in experimental unilateral hydronephrosis.
Berka JL; Alcorn D; Bertram JF; Ryan GB; Skinner SL
J Hypertens; 1994 Jul; 12(7):735-43. PubMed ID: 7963501
[TBL] [Abstract][Full Text] [Related]
17. Renin status of the afferent arteriole and ultrastructure of the juxtaglomerular apparatus in 'superficial' juxtamedullary nephrons from rats.
Casellas D; Taugner R
Ren Physiol; 1986; 9(6):348-56. PubMed ID: 3299564
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evidence that angiotensins I and II are formed by intracellular mechanism in juxtaglomerular cells.
Naruse K; Inagami T; Celio MR; Workman RJ; Takii Y
Hypertension; 1982; 4(3 Pt 2):70-4. PubMed ID: 6279509
[TBL] [Abstract][Full Text] [Related]
19. Morphology of the juxtaglomerular apparatus and secretory mechanisms.
Taugner R; Bührle CP; Hackenthal E; Mannek E; Nobiling R
Contrib Nephrol; 1984; 43():76-101. PubMed ID: 6091994
[No Abstract] [Full Text] [Related]
20. Immunoelectron microscopic localization of renin in the juxtaglomerular cells of the amphibian Bufo bufo.
Lamers AP; Stadhouders AM; Verhofstad AA; Michelakis AM
Gen Comp Endocrinol; 1985 Dec; 60(3):380-9. PubMed ID: 3935511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
